Global Biapenem Market

Biapenem Comprehensive Study by Type (150mg, 300mg, 600mg), Application (Sepsis, Pneumonia, Lung Abscess, Refractory Cystitis, Pyelonephritis, Peritonitis, Gynecologic Adnexitis), Sales Channel (Online, Offline) Players and Region - Global Market Outlook to 2026

Biapenem Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biapenem Market Scope?
Biapenem is a new carbapenem parenteral antibiotic with a broad spectrum of in vitro antibacterial activity that includes many gram-negative and gram-positive aerobic and anaerobic bacteria, including species that produce beta-lactamases. Biapenem is more stable to hydrolysis by human renal dihydro peptidase-I (DHP-I) than imipenem, meropenem, and panipenem and therefore does not require co-administration of a DHP-I inhibitor. After intravenous administration, biapenem is widely distributed and penetrates well into various tissues (e.g. lung tissue) and body fluids (e.g. sputum, pleural effusion, abdominal fluid). In randomized, non-blind, or double-blind clinical trials, Biapenem demonstrated good clinical and bacteriological efficacy (similar to imipenem/cilastatin) in the treatment of adult patients with intra-abdominal infections, lower respiratory tract infections, or complicated urinary tract infections. Biapenem is generally well tolerated. The most common side effects in clinical trials were rashes, nausea, and diarrhea.

The Biapenem market study is being classified by Type (150mg, 300mg and 600mg), by Application (Sepsis, Pneumonia, Lung Abscess, Refractory Cystitis, Pyelonephritis, Peritonitis and Gynecologic Adnexitis) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analysts at AMA predicts that Players from Asian will contribute to the maximum growth of Global Biapenem market throughout the predicted period.

Pfizer (United States), Meiji Holdings Co., Ltd. (Japan), Jiangsu Simcere Pharmaceutical Co., Ltd. (China), Shandong Luoxin Pharmacy (China), Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China) and CSPC Pharmaceutical Group Limited (China) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biapenem market by Type, Application and Region.

On the basis of geography, the market of Biapenem has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Upsurge in Novel Drug Applications
  • Increased Research and Development Activities

Market Drivers
  • Increased Prevalence of Bacterial Diseases
  • Increasing Importance of Generics
  • Increase in Demand for Antibiotics, owing to Increased Consumption in Low- and Middle-Income Countries

Opportunities
  • Growth in the Pharmaceutical Industry

Restraints
  • Several Side Effect Occurs due to high Consumption

Challenges
  • Presence of Several Alternatives


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Biapenem, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • 150mg
  • 300mg
  • 600mg
By Application
  • Sepsis
  • Pneumonia
  • Lung Abscess
  • Refractory Cystitis
  • Pyelonephritis
  • Peritonitis
  • Gynecologic Adnexitis
By Sales Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Bacterial Diseases
      • 3.2.2. Increasing Importance of Generics
      • 3.2.3. Increase in Demand for Antibiotics, owing to Increased Consumption in Low- and Middle-Income Countries
    • 3.3. Market Challenges
      • 3.3.1. Presence of Several Alternatives
    • 3.4. Market Trends
      • 3.4.1. Upsurge in Novel Drug Applications
      • 3.4.2. Increased Research and Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biapenem, by Type, Application, Sales Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biapenem (Value)
      • 5.2.1. Global Biapenem by: Type (Value)
        • 5.2.1.1. 150mg
        • 5.2.1.2. 300mg
        • 5.2.1.3. 600mg
      • 5.2.2. Global Biapenem by: Application (Value)
        • 5.2.2.1. Sepsis
        • 5.2.2.2. Pneumonia
        • 5.2.2.3. Lung Abscess
        • 5.2.2.4. Refractory Cystitis
        • 5.2.2.5. Pyelonephritis
        • 5.2.2.6. Peritonitis
        • 5.2.2.7. Gynecologic Adnexitis
      • 5.2.3. Global Biapenem by: Sales Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Biapenem Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Biapenem (Volume)
      • 5.3.1. Global Biapenem by: Type (Volume)
        • 5.3.1.1. 150mg
        • 5.3.1.2. 300mg
        • 5.3.1.3. 600mg
      • 5.3.2. Global Biapenem by: Application (Volume)
        • 5.3.2.1. Sepsis
        • 5.3.2.2. Pneumonia
        • 5.3.2.3. Lung Abscess
        • 5.3.2.4. Refractory Cystitis
        • 5.3.2.5. Pyelonephritis
        • 5.3.2.6. Peritonitis
        • 5.3.2.7. Gynecologic Adnexitis
      • 5.3.3. Global Biapenem by: Sales Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Biapenem Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Biapenem (Price)
      • 5.4.1. Global Biapenem by: Type (Price)
  • 6. Biapenem: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Meiji Holdings Co., Ltd. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Jiangsu Simcere Pharmaceutical Co., Ltd. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shandong Luoxin Pharmacy (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CSPC Pharmaceutical Group Limited (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Biapenem Sale, by Type, Application, Sales Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biapenem (Value)
      • 7.2.1. Global Biapenem by: Type (Value)
        • 7.2.1.1. 150mg
        • 7.2.1.2. 300mg
        • 7.2.1.3. 600mg
      • 7.2.2. Global Biapenem by: Application (Value)
        • 7.2.2.1. Sepsis
        • 7.2.2.2. Pneumonia
        • 7.2.2.3. Lung Abscess
        • 7.2.2.4. Refractory Cystitis
        • 7.2.2.5. Pyelonephritis
        • 7.2.2.6. Peritonitis
        • 7.2.2.7. Gynecologic Adnexitis
      • 7.2.3. Global Biapenem by: Sales Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Biapenem Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Biapenem (Volume)
      • 7.3.1. Global Biapenem by: Type (Volume)
        • 7.3.1.1. 150mg
        • 7.3.1.2. 300mg
        • 7.3.1.3. 600mg
      • 7.3.2. Global Biapenem by: Application (Volume)
        • 7.3.2.1. Sepsis
        • 7.3.2.2. Pneumonia
        • 7.3.2.3. Lung Abscess
        • 7.3.2.4. Refractory Cystitis
        • 7.3.2.5. Pyelonephritis
        • 7.3.2.6. Peritonitis
        • 7.3.2.7. Gynecologic Adnexitis
      • 7.3.3. Global Biapenem by: Sales Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Biapenem Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Biapenem (Price)
      • 7.4.1. Global Biapenem by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biapenem: by Type(USD Million)
  • Table 2. Biapenem 150mg , by Region USD Million (2015-2020)
  • Table 3. Biapenem 300mg , by Region USD Million (2015-2020)
  • Table 4. Biapenem 600mg , by Region USD Million (2015-2020)
  • Table 5. Biapenem: by Application(USD Million)
  • Table 6. Biapenem Sepsis , by Region USD Million (2015-2020)
  • Table 7. Biapenem Pneumonia , by Region USD Million (2015-2020)
  • Table 8. Biapenem Lung Abscess , by Region USD Million (2015-2020)
  • Table 9. Biapenem Refractory Cystitis , by Region USD Million (2015-2020)
  • Table 10. Biapenem Pyelonephritis , by Region USD Million (2015-2020)
  • Table 11. Biapenem Peritonitis , by Region USD Million (2015-2020)
  • Table 12. Biapenem Gynecologic Adnexitis , by Region USD Million (2015-2020)
  • Table 13. Biapenem: by Sales Channel(USD Million)
  • Table 14. Biapenem Online , by Region USD Million (2015-2020)
  • Table 15. Biapenem Offline , by Region USD Million (2015-2020)
  • Table 16. South America Biapenem, by Country USD Million (2015-2020)
  • Table 17. South America Biapenem, by Type USD Million (2015-2020)
  • Table 18. South America Biapenem, by Application USD Million (2015-2020)
  • Table 19. South America Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 20. Brazil Biapenem, by Type USD Million (2015-2020)
  • Table 21. Brazil Biapenem, by Application USD Million (2015-2020)
  • Table 22. Brazil Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 23. Argentina Biapenem, by Type USD Million (2015-2020)
  • Table 24. Argentina Biapenem, by Application USD Million (2015-2020)
  • Table 25. Argentina Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 26. Rest of South America Biapenem, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Biapenem, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 29. Asia Pacific Biapenem, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Biapenem, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Biapenem, by Application USD Million (2015-2020)
  • Table 32. Asia Pacific Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 33. China Biapenem, by Type USD Million (2015-2020)
  • Table 34. China Biapenem, by Application USD Million (2015-2020)
  • Table 35. China Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 36. Japan Biapenem, by Type USD Million (2015-2020)
  • Table 37. Japan Biapenem, by Application USD Million (2015-2020)
  • Table 38. Japan Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 39. India Biapenem, by Type USD Million (2015-2020)
  • Table 40. India Biapenem, by Application USD Million (2015-2020)
  • Table 41. India Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 42. South Korea Biapenem, by Type USD Million (2015-2020)
  • Table 43. South Korea Biapenem, by Application USD Million (2015-2020)
  • Table 44. South Korea Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 45. Taiwan Biapenem, by Type USD Million (2015-2020)
  • Table 46. Taiwan Biapenem, by Application USD Million (2015-2020)
  • Table 47. Taiwan Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 48. Australia Biapenem, by Type USD Million (2015-2020)
  • Table 49. Australia Biapenem, by Application USD Million (2015-2020)
  • Table 50. Australia Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Biapenem, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Biapenem, by Application USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 54. Europe Biapenem, by Country USD Million (2015-2020)
  • Table 55. Europe Biapenem, by Type USD Million (2015-2020)
  • Table 56. Europe Biapenem, by Application USD Million (2015-2020)
  • Table 57. Europe Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 58. Germany Biapenem, by Type USD Million (2015-2020)
  • Table 59. Germany Biapenem, by Application USD Million (2015-2020)
  • Table 60. Germany Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 61. France Biapenem, by Type USD Million (2015-2020)
  • Table 62. France Biapenem, by Application USD Million (2015-2020)
  • Table 63. France Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 64. Italy Biapenem, by Type USD Million (2015-2020)
  • Table 65. Italy Biapenem, by Application USD Million (2015-2020)
  • Table 66. Italy Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 67. United Kingdom Biapenem, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Biapenem, by Application USD Million (2015-2020)
  • Table 69. United Kingdom Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 70. Netherlands Biapenem, by Type USD Million (2015-2020)
  • Table 71. Netherlands Biapenem, by Application USD Million (2015-2020)
  • Table 72. Netherlands Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 73. Rest of Europe Biapenem, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Biapenem, by Application USD Million (2015-2020)
  • Table 75. Rest of Europe Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 76. MEA Biapenem, by Country USD Million (2015-2020)
  • Table 77. MEA Biapenem, by Type USD Million (2015-2020)
  • Table 78. MEA Biapenem, by Application USD Million (2015-2020)
  • Table 79. MEA Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 80. Middle East Biapenem, by Type USD Million (2015-2020)
  • Table 81. Middle East Biapenem, by Application USD Million (2015-2020)
  • Table 82. Middle East Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 83. Africa Biapenem, by Type USD Million (2015-2020)
  • Table 84. Africa Biapenem, by Application USD Million (2015-2020)
  • Table 85. Africa Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 86. North America Biapenem, by Country USD Million (2015-2020)
  • Table 87. North America Biapenem, by Type USD Million (2015-2020)
  • Table 88. North America Biapenem, by Application USD Million (2015-2020)
  • Table 89. North America Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 90. United States Biapenem, by Type USD Million (2015-2020)
  • Table 91. United States Biapenem, by Application USD Million (2015-2020)
  • Table 92. United States Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 93. Canada Biapenem, by Type USD Million (2015-2020)
  • Table 94. Canada Biapenem, by Application USD Million (2015-2020)
  • Table 95. Canada Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 96. Mexico Biapenem, by Type USD Million (2015-2020)
  • Table 97. Mexico Biapenem, by Application USD Million (2015-2020)
  • Table 98. Mexico Biapenem, by Sales Channel USD Million (2015-2020)
  • Table 99. Biapenem Sales: by Type(K Tons)
  • Table 100. Biapenem Sales 150mg , by Region K Tons (2015-2020)
  • Table 101. Biapenem Sales 300mg , by Region K Tons (2015-2020)
  • Table 102. Biapenem Sales 600mg , by Region K Tons (2015-2020)
  • Table 103. Biapenem Sales: by Application(K Tons)
  • Table 104. Biapenem Sales Sepsis , by Region K Tons (2015-2020)
  • Table 105. Biapenem Sales Pneumonia , by Region K Tons (2015-2020)
  • Table 106. Biapenem Sales Lung Abscess , by Region K Tons (2015-2020)
  • Table 107. Biapenem Sales Refractory Cystitis , by Region K Tons (2015-2020)
  • Table 108. Biapenem Sales Pyelonephritis , by Region K Tons (2015-2020)
  • Table 109. Biapenem Sales Peritonitis , by Region K Tons (2015-2020)
  • Table 110. Biapenem Sales Gynecologic Adnexitis , by Region K Tons (2015-2020)
  • Table 111. Biapenem Sales: by Sales Channel(K Tons)
  • Table 112. Biapenem Sales Online , by Region K Tons (2015-2020)
  • Table 113. Biapenem Sales Offline , by Region K Tons (2015-2020)
  • Table 114. South America Biapenem Sales, by Country K Tons (2015-2020)
  • Table 115. South America Biapenem Sales, by Type K Tons (2015-2020)
  • Table 116. South America Biapenem Sales, by Application K Tons (2015-2020)
  • Table 117. South America Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 118. Brazil Biapenem Sales, by Type K Tons (2015-2020)
  • Table 119. Brazil Biapenem Sales, by Application K Tons (2015-2020)
  • Table 120. Brazil Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 121. Argentina Biapenem Sales, by Type K Tons (2015-2020)
  • Table 122. Argentina Biapenem Sales, by Application K Tons (2015-2020)
  • Table 123. Argentina Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 124. Rest of South America Biapenem Sales, by Type K Tons (2015-2020)
  • Table 125. Rest of South America Biapenem Sales, by Application K Tons (2015-2020)
  • Table 126. Rest of South America Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 127. Asia Pacific Biapenem Sales, by Country K Tons (2015-2020)
  • Table 128. Asia Pacific Biapenem Sales, by Type K Tons (2015-2020)
  • Table 129. Asia Pacific Biapenem Sales, by Application K Tons (2015-2020)
  • Table 130. Asia Pacific Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 131. China Biapenem Sales, by Type K Tons (2015-2020)
  • Table 132. China Biapenem Sales, by Application K Tons (2015-2020)
  • Table 133. China Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 134. Japan Biapenem Sales, by Type K Tons (2015-2020)
  • Table 135. Japan Biapenem Sales, by Application K Tons (2015-2020)
  • Table 136. Japan Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 137. India Biapenem Sales, by Type K Tons (2015-2020)
  • Table 138. India Biapenem Sales, by Application K Tons (2015-2020)
  • Table 139. India Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 140. South Korea Biapenem Sales, by Type K Tons (2015-2020)
  • Table 141. South Korea Biapenem Sales, by Application K Tons (2015-2020)
  • Table 142. South Korea Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 143. Taiwan Biapenem Sales, by Type K Tons (2015-2020)
  • Table 144. Taiwan Biapenem Sales, by Application K Tons (2015-2020)
  • Table 145. Taiwan Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 146. Australia Biapenem Sales, by Type K Tons (2015-2020)
  • Table 147. Australia Biapenem Sales, by Application K Tons (2015-2020)
  • Table 148. Australia Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 149. Rest of Asia-Pacific Biapenem Sales, by Type K Tons (2015-2020)
  • Table 150. Rest of Asia-Pacific Biapenem Sales, by Application K Tons (2015-2020)
  • Table 151. Rest of Asia-Pacific Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 152. Europe Biapenem Sales, by Country K Tons (2015-2020)
  • Table 153. Europe Biapenem Sales, by Type K Tons (2015-2020)
  • Table 154. Europe Biapenem Sales, by Application K Tons (2015-2020)
  • Table 155. Europe Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 156. Germany Biapenem Sales, by Type K Tons (2015-2020)
  • Table 157. Germany Biapenem Sales, by Application K Tons (2015-2020)
  • Table 158. Germany Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 159. France Biapenem Sales, by Type K Tons (2015-2020)
  • Table 160. France Biapenem Sales, by Application K Tons (2015-2020)
  • Table 161. France Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 162. Italy Biapenem Sales, by Type K Tons (2015-2020)
  • Table 163. Italy Biapenem Sales, by Application K Tons (2015-2020)
  • Table 164. Italy Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 165. United Kingdom Biapenem Sales, by Type K Tons (2015-2020)
  • Table 166. United Kingdom Biapenem Sales, by Application K Tons (2015-2020)
  • Table 167. United Kingdom Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 168. Netherlands Biapenem Sales, by Type K Tons (2015-2020)
  • Table 169. Netherlands Biapenem Sales, by Application K Tons (2015-2020)
  • Table 170. Netherlands Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 171. Rest of Europe Biapenem Sales, by Type K Tons (2015-2020)
  • Table 172. Rest of Europe Biapenem Sales, by Application K Tons (2015-2020)
  • Table 173. Rest of Europe Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 174. MEA Biapenem Sales, by Country K Tons (2015-2020)
  • Table 175. MEA Biapenem Sales, by Type K Tons (2015-2020)
  • Table 176. MEA Biapenem Sales, by Application K Tons (2015-2020)
  • Table 177. MEA Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 178. Middle East Biapenem Sales, by Type K Tons (2015-2020)
  • Table 179. Middle East Biapenem Sales, by Application K Tons (2015-2020)
  • Table 180. Middle East Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 181. Africa Biapenem Sales, by Type K Tons (2015-2020)
  • Table 182. Africa Biapenem Sales, by Application K Tons (2015-2020)
  • Table 183. Africa Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 184. North America Biapenem Sales, by Country K Tons (2015-2020)
  • Table 185. North America Biapenem Sales, by Type K Tons (2015-2020)
  • Table 186. North America Biapenem Sales, by Application K Tons (2015-2020)
  • Table 187. North America Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 188. United States Biapenem Sales, by Type K Tons (2015-2020)
  • Table 189. United States Biapenem Sales, by Application K Tons (2015-2020)
  • Table 190. United States Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 191. Canada Biapenem Sales, by Type K Tons (2015-2020)
  • Table 192. Canada Biapenem Sales, by Application K Tons (2015-2020)
  • Table 193. Canada Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 194. Mexico Biapenem Sales, by Type K Tons (2015-2020)
  • Table 195. Mexico Biapenem Sales, by Application K Tons (2015-2020)
  • Table 196. Mexico Biapenem Sales, by Sales Channel K Tons (2015-2020)
  • Table 197. Biapenem: by Type(USD/Units)
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Biapenem: by Type(USD Million)
  • Table 205. Biapenem 150mg , by Region USD Million (2021-2026)
  • Table 206. Biapenem 300mg , by Region USD Million (2021-2026)
  • Table 207. Biapenem 600mg , by Region USD Million (2021-2026)
  • Table 208. Biapenem: by Application(USD Million)
  • Table 209. Biapenem Sepsis , by Region USD Million (2021-2026)
  • Table 210. Biapenem Pneumonia , by Region USD Million (2021-2026)
  • Table 211. Biapenem Lung Abscess , by Region USD Million (2021-2026)
  • Table 212. Biapenem Refractory Cystitis , by Region USD Million (2021-2026)
  • Table 213. Biapenem Pyelonephritis , by Region USD Million (2021-2026)
  • Table 214. Biapenem Peritonitis , by Region USD Million (2021-2026)
  • Table 215. Biapenem Gynecologic Adnexitis , by Region USD Million (2021-2026)
  • Table 216. Biapenem: by Sales Channel(USD Million)
  • Table 217. Biapenem Online , by Region USD Million (2021-2026)
  • Table 218. Biapenem Offline , by Region USD Million (2021-2026)
  • Table 219. South America Biapenem, by Country USD Million (2021-2026)
  • Table 220. South America Biapenem, by Type USD Million (2021-2026)
  • Table 221. South America Biapenem, by Application USD Million (2021-2026)
  • Table 222. South America Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 223. Brazil Biapenem, by Type USD Million (2021-2026)
  • Table 224. Brazil Biapenem, by Application USD Million (2021-2026)
  • Table 225. Brazil Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 226. Argentina Biapenem, by Type USD Million (2021-2026)
  • Table 227. Argentina Biapenem, by Application USD Million (2021-2026)
  • Table 228. Argentina Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 229. Rest of South America Biapenem, by Type USD Million (2021-2026)
  • Table 230. Rest of South America Biapenem, by Application USD Million (2021-2026)
  • Table 231. Rest of South America Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 232. Asia Pacific Biapenem, by Country USD Million (2021-2026)
  • Table 233. Asia Pacific Biapenem, by Type USD Million (2021-2026)
  • Table 234. Asia Pacific Biapenem, by Application USD Million (2021-2026)
  • Table 235. Asia Pacific Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 236. China Biapenem, by Type USD Million (2021-2026)
  • Table 237. China Biapenem, by Application USD Million (2021-2026)
  • Table 238. China Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 239. Japan Biapenem, by Type USD Million (2021-2026)
  • Table 240. Japan Biapenem, by Application USD Million (2021-2026)
  • Table 241. Japan Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 242. India Biapenem, by Type USD Million (2021-2026)
  • Table 243. India Biapenem, by Application USD Million (2021-2026)
  • Table 244. India Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 245. South Korea Biapenem, by Type USD Million (2021-2026)
  • Table 246. South Korea Biapenem, by Application USD Million (2021-2026)
  • Table 247. South Korea Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 248. Taiwan Biapenem, by Type USD Million (2021-2026)
  • Table 249. Taiwan Biapenem, by Application USD Million (2021-2026)
  • Table 250. Taiwan Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 251. Australia Biapenem, by Type USD Million (2021-2026)
  • Table 252. Australia Biapenem, by Application USD Million (2021-2026)
  • Table 253. Australia Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 254. Rest of Asia-Pacific Biapenem, by Type USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Biapenem, by Application USD Million (2021-2026)
  • Table 256. Rest of Asia-Pacific Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 257. Europe Biapenem, by Country USD Million (2021-2026)
  • Table 258. Europe Biapenem, by Type USD Million (2021-2026)
  • Table 259. Europe Biapenem, by Application USD Million (2021-2026)
  • Table 260. Europe Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 261. Germany Biapenem, by Type USD Million (2021-2026)
  • Table 262. Germany Biapenem, by Application USD Million (2021-2026)
  • Table 263. Germany Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 264. France Biapenem, by Type USD Million (2021-2026)
  • Table 265. France Biapenem, by Application USD Million (2021-2026)
  • Table 266. France Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 267. Italy Biapenem, by Type USD Million (2021-2026)
  • Table 268. Italy Biapenem, by Application USD Million (2021-2026)
  • Table 269. Italy Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 270. United Kingdom Biapenem, by Type USD Million (2021-2026)
  • Table 271. United Kingdom Biapenem, by Application USD Million (2021-2026)
  • Table 272. United Kingdom Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 273. Netherlands Biapenem, by Type USD Million (2021-2026)
  • Table 274. Netherlands Biapenem, by Application USD Million (2021-2026)
  • Table 275. Netherlands Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 276. Rest of Europe Biapenem, by Type USD Million (2021-2026)
  • Table 277. Rest of Europe Biapenem, by Application USD Million (2021-2026)
  • Table 278. Rest of Europe Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 279. MEA Biapenem, by Country USD Million (2021-2026)
  • Table 280. MEA Biapenem, by Type USD Million (2021-2026)
  • Table 281. MEA Biapenem, by Application USD Million (2021-2026)
  • Table 282. MEA Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 283. Middle East Biapenem, by Type USD Million (2021-2026)
  • Table 284. Middle East Biapenem, by Application USD Million (2021-2026)
  • Table 285. Middle East Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 286. Africa Biapenem, by Type USD Million (2021-2026)
  • Table 287. Africa Biapenem, by Application USD Million (2021-2026)
  • Table 288. Africa Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 289. North America Biapenem, by Country USD Million (2021-2026)
  • Table 290. North America Biapenem, by Type USD Million (2021-2026)
  • Table 291. North America Biapenem, by Application USD Million (2021-2026)
  • Table 292. North America Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 293. United States Biapenem, by Type USD Million (2021-2026)
  • Table 294. United States Biapenem, by Application USD Million (2021-2026)
  • Table 295. United States Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 296. Canada Biapenem, by Type USD Million (2021-2026)
  • Table 297. Canada Biapenem, by Application USD Million (2021-2026)
  • Table 298. Canada Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 299. Mexico Biapenem, by Type USD Million (2021-2026)
  • Table 300. Mexico Biapenem, by Application USD Million (2021-2026)
  • Table 301. Mexico Biapenem, by Sales Channel USD Million (2021-2026)
  • Table 302. Biapenem Sales: by Type(K Tons)
  • Table 303. Biapenem Sales 150mg , by Region K Tons (2021-2026)
  • Table 304. Biapenem Sales 300mg , by Region K Tons (2021-2026)
  • Table 305. Biapenem Sales 600mg , by Region K Tons (2021-2026)
  • Table 306. Biapenem Sales: by Application(K Tons)
  • Table 307. Biapenem Sales Sepsis , by Region K Tons (2021-2026)
  • Table 308. Biapenem Sales Pneumonia , by Region K Tons (2021-2026)
  • Table 309. Biapenem Sales Lung Abscess , by Region K Tons (2021-2026)
  • Table 310. Biapenem Sales Refractory Cystitis , by Region K Tons (2021-2026)
  • Table 311. Biapenem Sales Pyelonephritis , by Region K Tons (2021-2026)
  • Table 312. Biapenem Sales Peritonitis , by Region K Tons (2021-2026)
  • Table 313. Biapenem Sales Gynecologic Adnexitis , by Region K Tons (2021-2026)
  • Table 314. Biapenem Sales: by Sales Channel(K Tons)
  • Table 315. Biapenem Sales Online , by Region K Tons (2021-2026)
  • Table 316. Biapenem Sales Offline , by Region K Tons (2021-2026)
  • Table 317. South America Biapenem Sales, by Country K Tons (2021-2026)
  • Table 318. South America Biapenem Sales, by Type K Tons (2021-2026)
  • Table 319. South America Biapenem Sales, by Application K Tons (2021-2026)
  • Table 320. South America Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 321. Brazil Biapenem Sales, by Type K Tons (2021-2026)
  • Table 322. Brazil Biapenem Sales, by Application K Tons (2021-2026)
  • Table 323. Brazil Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 324. Argentina Biapenem Sales, by Type K Tons (2021-2026)
  • Table 325. Argentina Biapenem Sales, by Application K Tons (2021-2026)
  • Table 326. Argentina Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 327. Rest of South America Biapenem Sales, by Type K Tons (2021-2026)
  • Table 328. Rest of South America Biapenem Sales, by Application K Tons (2021-2026)
  • Table 329. Rest of South America Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 330. Asia Pacific Biapenem Sales, by Country K Tons (2021-2026)
  • Table 331. Asia Pacific Biapenem Sales, by Type K Tons (2021-2026)
  • Table 332. Asia Pacific Biapenem Sales, by Application K Tons (2021-2026)
  • Table 333. Asia Pacific Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 334. China Biapenem Sales, by Type K Tons (2021-2026)
  • Table 335. China Biapenem Sales, by Application K Tons (2021-2026)
  • Table 336. China Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 337. Japan Biapenem Sales, by Type K Tons (2021-2026)
  • Table 338. Japan Biapenem Sales, by Application K Tons (2021-2026)
  • Table 339. Japan Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 340. India Biapenem Sales, by Type K Tons (2021-2026)
  • Table 341. India Biapenem Sales, by Application K Tons (2021-2026)
  • Table 342. India Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 343. South Korea Biapenem Sales, by Type K Tons (2021-2026)
  • Table 344. South Korea Biapenem Sales, by Application K Tons (2021-2026)
  • Table 345. South Korea Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 346. Taiwan Biapenem Sales, by Type K Tons (2021-2026)
  • Table 347. Taiwan Biapenem Sales, by Application K Tons (2021-2026)
  • Table 348. Taiwan Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 349. Australia Biapenem Sales, by Type K Tons (2021-2026)
  • Table 350. Australia Biapenem Sales, by Application K Tons (2021-2026)
  • Table 351. Australia Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 352. Rest of Asia-Pacific Biapenem Sales, by Type K Tons (2021-2026)
  • Table 353. Rest of Asia-Pacific Biapenem Sales, by Application K Tons (2021-2026)
  • Table 354. Rest of Asia-Pacific Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 355. Europe Biapenem Sales, by Country K Tons (2021-2026)
  • Table 356. Europe Biapenem Sales, by Type K Tons (2021-2026)
  • Table 357. Europe Biapenem Sales, by Application K Tons (2021-2026)
  • Table 358. Europe Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 359. Germany Biapenem Sales, by Type K Tons (2021-2026)
  • Table 360. Germany Biapenem Sales, by Application K Tons (2021-2026)
  • Table 361. Germany Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 362. France Biapenem Sales, by Type K Tons (2021-2026)
  • Table 363. France Biapenem Sales, by Application K Tons (2021-2026)
  • Table 364. France Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 365. Italy Biapenem Sales, by Type K Tons (2021-2026)
  • Table 366. Italy Biapenem Sales, by Application K Tons (2021-2026)
  • Table 367. Italy Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 368. United Kingdom Biapenem Sales, by Type K Tons (2021-2026)
  • Table 369. United Kingdom Biapenem Sales, by Application K Tons (2021-2026)
  • Table 370. United Kingdom Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 371. Netherlands Biapenem Sales, by Type K Tons (2021-2026)
  • Table 372. Netherlands Biapenem Sales, by Application K Tons (2021-2026)
  • Table 373. Netherlands Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 374. Rest of Europe Biapenem Sales, by Type K Tons (2021-2026)
  • Table 375. Rest of Europe Biapenem Sales, by Application K Tons (2021-2026)
  • Table 376. Rest of Europe Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 377. MEA Biapenem Sales, by Country K Tons (2021-2026)
  • Table 378. MEA Biapenem Sales, by Type K Tons (2021-2026)
  • Table 379. MEA Biapenem Sales, by Application K Tons (2021-2026)
  • Table 380. MEA Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 381. Middle East Biapenem Sales, by Type K Tons (2021-2026)
  • Table 382. Middle East Biapenem Sales, by Application K Tons (2021-2026)
  • Table 383. Middle East Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 384. Africa Biapenem Sales, by Type K Tons (2021-2026)
  • Table 385. Africa Biapenem Sales, by Application K Tons (2021-2026)
  • Table 386. Africa Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 387. North America Biapenem Sales, by Country K Tons (2021-2026)
  • Table 388. North America Biapenem Sales, by Type K Tons (2021-2026)
  • Table 389. North America Biapenem Sales, by Application K Tons (2021-2026)
  • Table 390. North America Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 391. United States Biapenem Sales, by Type K Tons (2021-2026)
  • Table 392. United States Biapenem Sales, by Application K Tons (2021-2026)
  • Table 393. United States Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 394. Canada Biapenem Sales, by Type K Tons (2021-2026)
  • Table 395. Canada Biapenem Sales, by Application K Tons (2021-2026)
  • Table 396. Canada Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 397. Mexico Biapenem Sales, by Type K Tons (2021-2026)
  • Table 398. Mexico Biapenem Sales, by Application K Tons (2021-2026)
  • Table 399. Mexico Biapenem Sales, by Sales Channel K Tons (2021-2026)
  • Table 400. Biapenem: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biapenem: by Type USD Million (2015-2020)
  • Figure 5. Global Biapenem: by Application USD Million (2015-2020)
  • Figure 6. Global Biapenem: by Sales Channel USD Million (2015-2020)
  • Figure 7. South America Biapenem Share (%), by Country
  • Figure 8. Asia Pacific Biapenem Share (%), by Country
  • Figure 9. Europe Biapenem Share (%), by Country
  • Figure 10. MEA Biapenem Share (%), by Country
  • Figure 11. North America Biapenem Share (%), by Country
  • Figure 12. Global Biapenem: by Type K Tons (2015-2020)
  • Figure 13. Global Biapenem: by Application K Tons (2015-2020)
  • Figure 14. Global Biapenem: by Sales Channel K Tons (2015-2020)
  • Figure 15. South America Biapenem Share (%), by Country
  • Figure 16. Asia Pacific Biapenem Share (%), by Country
  • Figure 17. Europe Biapenem Share (%), by Country
  • Figure 18. MEA Biapenem Share (%), by Country
  • Figure 19. North America Biapenem Share (%), by Country
  • Figure 20. Global Biapenem: by Type USD/Units (2015-2020)
  • Figure 21. Global Biapenem share by Players 2020 (%)
  • Figure 22. Global Biapenem share by Players (Top 3) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 25. Pfizer (United States) Revenue: by Geography 2020
  • Figure 26. Meiji Holdings Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Meiji Holdings Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 28. Jiangsu Simcere Pharmaceutical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 29. Jiangsu Simcere Pharmaceutical Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 30. Shandong Luoxin Pharmacy (China) Revenue, Net Income and Gross profit
  • Figure 31. Shandong Luoxin Pharmacy (China) Revenue: by Geography 2020
  • Figure 32. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 33. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 34. CSPC Pharmaceutical Group Limited (China) Revenue, Net Income and Gross profit
  • Figure 35. CSPC Pharmaceutical Group Limited (China) Revenue: by Geography 2020
  • Figure 36. Global Biapenem: by Type USD Million (2021-2026)
  • Figure 37. Global Biapenem: by Application USD Million (2021-2026)
  • Figure 38. Global Biapenem: by Sales Channel USD Million (2021-2026)
  • Figure 39. South America Biapenem Share (%), by Country
  • Figure 40. Asia Pacific Biapenem Share (%), by Country
  • Figure 41. Europe Biapenem Share (%), by Country
  • Figure 42. MEA Biapenem Share (%), by Country
  • Figure 43. North America Biapenem Share (%), by Country
  • Figure 44. Global Biapenem: by Type K Tons (2021-2026)
  • Figure 45. Global Biapenem: by Application K Tons (2021-2026)
  • Figure 46. Global Biapenem: by Sales Channel K Tons (2021-2026)
  • Figure 47. South America Biapenem Share (%), by Country
  • Figure 48. Asia Pacific Biapenem Share (%), by Country
  • Figure 49. Europe Biapenem Share (%), by Country
  • Figure 50. MEA Biapenem Share (%), by Country
  • Figure 51. North America Biapenem Share (%), by Country
  • Figure 52. Global Biapenem: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Meiji Holdings Co., Ltd. (Japan)
  • Jiangsu Simcere Pharmaceutical Co., Ltd. (China)
  • Shandong Luoxin Pharmacy (China)
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China)
  • CSPC Pharmaceutical Group Limited (China)
Select User Access Type

Key Highlights of Report


Jun 2021 218 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biapenem Market Quantitative research analysis
Global Biapenem Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Biapenem market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Biapenem market are Pfizer (United States), Meiji Holdings Co., Ltd. (Japan), Jiangsu Simcere Pharmaceutical Co., Ltd. (China), Shandong Luoxin Pharmacy (China), Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (China) and CSPC Pharmaceutical Group Limited (China), to name a few.
In this highly competitive & fast evolving Biapenem industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Biapenem Market Report?

Have a Query? Click Here

Other Related Reports

Soliris Comprehensive Study by Category (Plasma Exchange, Plasma Infusion), Indication (Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH), Generalized Myasthenia Gr...
$ 3450
Antispasmodics Drugs Comprehensive Study by Type (Dicyclomine Hydrochloride, Loperamide Hydrochloride, Others), Route of Administration (Oral, Injectable, Sublingual, Others), Indication (Irritable B...
$ 3750
Hashimoto's Thyroiditis Drug Comprehensive Study by Type (Capsule, Powder, Tablet), Application (Hospitals, Clinics, Medical Laboratories, Others), Treatment (Levothyroxine, Triiodothyronine, Desicca...
$ 3750
Gilenya Comprehensive Study by Indication (Clinically Isolated Syndrome (CIS), Relapsing-Remitting MS (RRMS), Primary Progressive MS (PPMS), Secondary Progressive MS (SPMS)), Distribution (Hospital D...
$ 3450
Norepinephrine Drug Comprehensive Study by Application (Neurogenic Shock, Septic Shock, Others), Administration (Oral, Intravenous), Form (Tablets, Injectables, Pills, Others), Distribution (Hospital...
$ 3450
Artesunate Drugs Comprehensive Study by Administration (Intravenously, Intramuscularly), Category (Monoaromatic Artesunate, Compound Artesunate), Form (Tablet, Injection, Others), Indication (Malaria...
$ 3650